Pokladnikova Jitka, Meyboom Ronald H B, Meincke Ricarda, Niedrig David, Russmann Stefan
Department of Social and Clinical Pharmacy, Faculty of Pharmacy in Hradec Kralove, Charles University in Prague, Heyrovskeho 1203, 50005, Hradec Kralove, Czech Republic.
WHO Collaborating Centre for International Drug Monitoring, Uppsala Monitoring Centre, Uppsala, Sweden.
Drug Saf. 2016 May;39(5):455-64. doi: 10.1007/s40264-016-0401-5.
Herbal medicines are used worldwide and with an increasing popularity in Western countries. Although often perceived as 'naturally safe', herbals may cause severe adverse drug reactions (ADRs), with immediate allergic reactions being particularly life threatening.
The aim of this study was to analyse immediate allergy-like ADRs to herbals documented in VigiBase®, the WHO international pharmacovigilance database.
The documentation of all suspected ADRs in association with herbal exposure reported to VigiBase® from 1969 to August 2014 was retrieved. Among all reports in which WHO-ART reaction terms were indicative of acute allergic reactions, those classified as 'suspect' with a documented causality assessment and latency time of ≤1 day were selected. For the most frequent specific herbal-ADR combinations, the information component (IC) as a measure of disproportionality based on Bayesian statistics was calculated.
We identified 757 reports out of 1039 ADRs. Products with mixed herbals (36.0 %) as well as those administered orally (63.2 %) were predominant. The most frequent reactions were urticaria and rash (49.2 %). Anaphylactic reactions accounted for 9.5 %. Disproportionally frequent reporting of mouth edema (IC = 1.81) and anaphylactic reactions (IC = 1.24) to Phleum pretense were noted.
Our findings indicate that herbal medicines for oral use carry a risk of causing immediate allergy-like ADRs. Studies using the Vigibase® database can identify specific combinations of particular herbs and adverse reactions. Healthcare professionals and patients should be aware of these risks and report any serious adverse experiences.
草药在全球范围内被使用,并且在西方国家越来越受欢迎。尽管草药通常被认为“天然安全”,但它们可能会引起严重的药物不良反应(ADR),其中即刻过敏反应尤其危及生命。
本研究的目的是分析世界卫生组织国际药物警戒数据库VigiBase®中记录的草药引起的即刻过敏样ADR。
检索了1969年至2014年8月期间向VigiBase®报告的所有与草药暴露相关的疑似ADR记录。在所有世界卫生组织药物不良反应术语表明为急性过敏反应的报告中,选择那些分类为“疑似”且有记录的因果关系评估且潜伏时间≤1天的报告。对于最常见的特定草药-ADR组合,计算基于贝叶斯统计的信息成分(IC)作为不成比例的度量。
我们在1039例ADR中识别出757份报告。混合草药产品(36.0%)以及口服给药的产品(63.2%)占主导。最常见的反应是荨麻疹和皮疹(49.2%)。过敏反应占9.5%。注意到对猫尾草的口腔水肿(IC = 1.81)和过敏反应(IC = 1.24)报告不成比例地频繁。
我们的研究结果表明,口服草药有引起即刻过敏样ADR的风险。使用VigiBase®数据库的研究可以识别特定草药与不良反应的具体组合。医疗保健专业人员和患者应意识到这些风险,并报告任何严重的不良经历。